<Header>
<FileStats>
    <FileName>20241016_10-K-A_edgar_data_1715819_0001437749-24-031282.txt</FileName>
    <GrossFileSize>306604</GrossFileSize>
    <NetFileSize>12376</NetFileSize>
    <NonText_DocumentType_Chars>105289</NonText_DocumentType_Chars>
    <HTML_Chars>57776</HTML_Chars>
    <XBRL_Chars>68454</XBRL_Chars>
    <XML_Chars>56881</XML_Chars>
    <N_Exhibits>6</N_Exhibits>
</FileStats>
<SEC-Header>
0001437749-24-031282.hdr.sgml : 20241016
<ACCEPTANCE-DATETIME>20241015185152
ACCESSION NUMBER:		0001437749-24-031282
CONFORMED SUBMISSION TYPE:	10-K/A
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20241016
DATE AS OF CHANGE:		20241015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Electromedical Technologies, Inc
		CENTRAL INDEX KEY:			0001715819
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				822619815
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-56192
		FILM NUMBER:		241373001

	BUSINESS ADDRESS:	
		STREET 1:		16561 N 92ND STREET
		STREET 2:		SUITE 101
		CITY:			SCOTTSDALE
		STATE:			AZ
		ZIP:			85260
		BUSINESS PHONE:		888-880-7888

	MAIL ADDRESS:	
		STREET 1:		16561 N 92ND STREET
		STREET 2:		SUITE 101
		CITY:			SCOTTSDALE
		STATE:			AZ
		ZIP:			85260

</SEC-Header>
</Header>

 0001437749-24-031282.txt : 20241016

10-K/A
 1
 emed20231231_10ka.htm
 FORM 10-K/A

emed20231231_10ka.htm 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

FORM 

(Mark One) 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the Fiscal Year Ended 

Or 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the Transition Period From to

Commission File Number 

(Exact name of registrant as specified in its charter)

(State or Other Jurisdiction of

Incorporation)

5047 

(Primary Standard Industrial

Classification Code Number)

(I.R.S. Employer

Identification No.)

, 

, 

(Address of principal executive offices)

(Zip Code)

) 

(Registrant s telephone number, including area code)

Securities Registered pursuant to Section 12(g) of the Act

Title of Each Class 

Trading Symbol(s) 

Name of each Exchange on which Registered 

None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). No 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (( 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.

Large accelerated filer 

Accelerated filer 

Smaller reporting company 

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant has filed a report on and attestation to its management s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant s executive officers during the relevant recovery period pursuant to 240.10D-1(b). 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No 

The aggregate market value of common equity held by non-affiliates of the Registrant as of December 31, 2023 was approximately .

As at both December 31, 2023, and April 15, 2024, 2023, 463,286,208 and shares of common stock, par value 0.00001, were issued and outstanding.

1

Documents incorporated by reference: 

None.

Auditor Name 
			 Auditor Location 
			 Auditor Firm ID 

EXPLANATORY NOTE 

Exhibit No. 

Description of Exhibit 

Location 

31.1/A 
			 
			 Amended Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a). 
			 
			 Filed herewith. 

31.2/A 
			 
			 Amended Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a). 
			 
			 Filed herewith. 

104 
			 
			 Cover Page Interactive Data File (formatted as Inline XBRL) 

SIGNATURES 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: October 15, 2024

By:

/s/Matthew Wolfson 

Matthew Wolfson

Chief Executive Officer, Chief

Financial Officer

2

<EX-31.1A>
 2
 ex_730393.htm
 EXHIBIT 31.1A

ex_730393.htm 

Exhibit 31.1/A. Certification by Chief Executive Officer 

I, Matthew Wolfson, certify that: 

1. I have reviewed the Annual Report on Form 10-K, as amended by this Form 10-K/A, of Electromedical Technologies, Inc. for the year ended December 31, 2023; 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. 

Date: October 15, 2024 

 /s/ Matthew Wolfson 

 Matthew Wolfson 

 Chief Executive Officer 

</EX-31.1A>

<EX-31.2A>
 3
 ex_730394.htm
 EXHIBIT 31.2A

ex_730394.htm 

Exhibit 31.2/A. Certification by Chief Financial Officer 

I, Matthew Wolfson, certify that: 

1. I have reviewed the Annual Report on Form 10-K, as amended by this Form 10-K/A, of Electromedical Technologies, Inc. for the year ended December 31, 2023; 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. 

Date: October 15, 2024 

/s/ Matthew Wolfson 

 Matthew Wolfson, 

 Chief Financial Officer 

</EX-31.2A>

<EX-101.SCH>
 4
 emed-20231231.xsd
 XBRL TAXONOMY EXTENSION SCHEMA

</EX-101.SCH>

<EX-101.DEF>
 5
 emed-20231231_def.xml
 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE

</EX-101.DEF>

<EX-101.LAB>
 6
 emed-20231231_lab.xml
 XBRL TAXONOMY EXTENSION LABEL LINKBASE

</EX-101.LAB>

<EX-101.PRE>
 7
 emed-20231231_pre.xml
 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

</EX-101.PRE>

